Hafsa Farooq

Hafsa Farooq

Auto-generated profile, based on publicly available information

Hafsa Farooq

Georgia State University

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 May 2023 in bioRxiv
Verified
Preprint
Open access
PDF file
DYDottie Yu
Dottie Yu
RARam Ayyala
Ram Ayyala
SSSarah Hany Sadek
Sarah Hany Sadek
LCLikhitha Chittampalli
Likhitha Chittampalli
HFHafsa Farooq
Hafsa Farooq
SMSerghei Mangul
Serghei Mangul
Accurate identification of human leukocyte antigen (HLA) alleles is essential for various clinical and research applications, such as transplant matching and drug sensitivities. Recent advances in RNA-seq technology have made it possible to impute HLA types from high throughput sequencing data, spurring the development of a large number of computational HLA typing tools. However, the relative performance of these tools is unknown, limiting the ability for clinical and biomedical research to make informed choices regarding which tools to use. Here, we rigorously compare the performance of 9 HLA callers on 652 RNA-seq samples across 6 datasets with molecularly defined gold standard. We find that OptiType has the highest accuracy at both low and high resolution with an accuracy above 99%, followed by arcasHLA and seq2HLA with accuracies above 96%. Despite OptiType’s high accuracy, it is only capable of Class I predictions, thereby limiting its application to clinical procedures like transplantation requiring Class II predictions. Furthermore, our findings reveal significant variation in accuracy across each HLA locus, with HLA-A exhibiting the highest accuracy and HLA-DRB1 exhibiting the lowest accuracy. We also find that class II genes are generally more challenging to impute than class I genes, with most typing algorithms capable of making Class I predictions to >97% accuracy whereas the best Class II tool predicts with 94.2% accuracy. Moreover, we identify notable differences in the computational resources necessary to run each tool. We find that the most computationally expensive tools are OptiType and HLA-HD which require 105 and 102 times greater RAM and CPU, respectively, than the least computationally expensive tools, seq2HLA and RNA2HLA. Furthermore, all tools have decreased accuracy for African samples with respect to European samples at four digit resolution. We conclude that RNA-Seq HLA callers are capable of returning high-quality results, but the tools that offer a good balance between accuracy, consistency, and computational expensiveness are yet to be developed.

1 February 2025 in Journal of Computational Biology
Verified
Journal Article
Closed access
FRFilipp Rondel
Filipp Rondel
HFHafsa Farooq
Hafsa Farooq
RHRoya Hosseini
Roya Hosseini
AJAkshay Juyal
Akshay Juyal
SKSergey Knyazev
Sergey Knyazev
Alex ZelikovskyAlex Zelikovsky
Alex Zelikovsky
Evaluating changes in metabolic pathway activity is essential for studying disease mechanisms and developing new treatments, with significant benefits extending to human health. Here, we propose EMPathways2, a maximum likelihood pipeline that is based on the expectation-maximization algorithm, which is capable of evaluating enzyme expression and metabolic pathway activity level. We first estimate enzyme expression from RNA-seq data that is used for simultaneous estimation of pathway activity levels using enzyme participation levels in each pathway. We implement the novel pipeline to RNA-seq data from several groups of mice, which provides a deeper look at the biochemical changes occurring as a result of bacterial infection, disease, and immune response. Our results show that estimated enzyme expression, pathway activity levels, and enzyme participation levels in each pathway are robust and stable across all samples. Estimated activity levels of a significant number of metabolic pathways strongly correlate with the infected and uninfected status of the respective rodent types.

8 October 2023
Verified
Book Chapter
Closed access
PDF file
HFHafsa Farooq
Hafsa Farooq
DNDaniel Novikov
Daniel Novikov
AJAkshay Juyal
Akshay Juyal
Alex ZelikovskyAlex Zelikovsky
Alex Zelikovsky

1 November 2025
Verified
Book Chapter
Closed access
PDF file
RARyan Alomair
Ryan Alomair
HFHafsa Farooq
Hafsa Farooq
DNDaniel Novikov
Daniel Novikov
AJAkshay Juyal
Akshay Juyal
Alex ZelikovskyAlex Zelikovsky
Alex Zelikovsky